Year: 2026
Type: article
Abstract: ABSTRACT We describe the design and synthesis of α‐azido‐4‐thioribose and α‐epoxycarbaribose‐based adenosine diphosphate ribose (ADP‐ribose) analogs as potent inhibitors of the SARS‐CoV‐2 macrodomain Mac1. The α‐epoxycarbaribose was designed to emulate the structure of the distal ribose of ADPr, which adopts an E 3 conformation during hydrolysis and release from the target protein. In addition, a sulfonyl carbamate linker and the remdesivir‐inspired nucleobase GS‐441524 were incorporated into our designs to increase inhibitor lipophilicity and potency, respectively. The α‐epoxycarbaribose GS‐441524 pyrophosphate was identified as the most potent Mac1 inhibitor to date, exhibiting low‐nanomolar affinity. Replacing pyrophosphate with the less polar sulfonyl carbamate linker yielded an inhibitor with an IC50 of 19 nM. Analysis of co‐crystal structures of Mac1 and its inhibitors showed that the epoxide is intact and revealed that the sulfonyl carbamate linker positions itself to mimic pyrophosphate binding.
Source: Chemistry - A European Journal
DOI: 10.1002/chem.71898
Institutions: Leiden University, University of Oxford
Language: English
Subfield: Organic Chemistry
Field: Chemistry
Domain: Physical Sciences
Open Access status: hybrid
Estimated APC paid: $4,640
Awards: G1938278208, Reversible ADP-ribosylation signaling in the control of coronavirus infection, ADP-ribosylation signalling in genome stability, ADP-ribosylation of DNA in Mycobacterium tuberculosis, Understanding the activity and role of DarTG, a toxin:antitoxin system responsible for a novel DNA modification, G9001368949
OpenAlex ID: W7230749558
